TickerFacts.

Biolife Solutions Inc (BLFS): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$96.21M
Year ended 2025-12-31
$119.16M2017-12-31: $11.02M2018-12-31: $19.74M2019-12-31: $27.37M2020-12-31: $48.09M2021-12-31: $119.16M2022-12-31: $76.24M2023-12-31: $68.02M2024-12-31: $74.65M2025-12-31: $96.21M$96.21M
2017-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$96.21M+28.9%2026-02-26, From 2025-01-01
2024-12-31$74.65M+9.7%2026-02-26, From 2024-01-01
2023-12-31$68.02Mn/c2026-02-26, From 2023-01-01
2022-12-31$76.24M-36.0%2025-03-03, From 2022-01-01
2021-12-31$119.16M+147.8%2024-02-29, From 2021-01-01
2020-12-31$48.09M+75.7%2023-03-31, From 2020-01-01
2019-12-31$27.37M+38.6%2022-03-31, From 2019-01-01
2018-12-31$19.74M+79.1%2020-05-15, From 2018-01-01
2017-12-31$11.02Mn/a2019-03-15, From 2017-01-01

Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Biolife Solutions Inc (BLFS)2025-12-31$96.21M+28.9%
Vaso Corp (VASO)2025-12-31$89.10M+2.7%
Ceribell, Inc. (CBLL)2025-12-31$89.06M+36.1%
Outset Medical, Inc. (OM)2025-12-31$119.48M+5.1%
Electromed, Inc. (ELMD)2026-06-30$73.78M+15.3%
Iridex Corp (IRIX)2026-01-03$52.67M+8.2%
Axogen, Inc. (AXGN)2025-12-31$225.21M+20.2%
Stereotaxis, Inc. (STXS)2025-12-31$32.38M+20.3%
electroCore, Inc. (ECOR)2025-12-31$32.03M+27.2%

Compare BLFS, VASO, CBLL, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗